Launch of APT™ T3X Topical Formulation for COVID-19
While research across the globe for treatment of COVID-19 is in progress, the firm Patient Focused Tele-Health , LLC (Advanced Penetration Technology, LLC) carried out research and emerged with a non-prescription topical formulation APT™ T3X Topical Formulation (Tetracycline 3% Ointment) and claimed that it will play an important role in mitigating, decreasing and preventing the spread and severity of COVID-19 illness.
The antiviral studies of APT™ T3X resulted in significant efficacy of the formulation against Influenza A virus and Corona virus. With the studies done so far, APT™ T3X controlled the infections being caused by Coronavirus NL63. However, the additional efficacy of the formulation has to established with the future studies.
Daily use of APT™ T3X nasal swab within each nasal cavity every 12 hours helps in controlling the COVID-19 symptoms and is suggested for front-line warriors. Non-symptomatic COVID-19 patients do benefit with it by swabbing the product within nasal cavity every 12 hours.
For updates on it, keep visiting the website, https://www.aptdeliverysystem.com/
